The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.
The European commission plans to give a new 15-year lease to a controversial weedkiller that was deemed “probably carcinogenic to humans” by the World Health Organisation’s International Agency for Research on Cancer (IARC).
A draft implementing law seen by the Guardian says the commission has decided it is appropriate to renew the licence for glyphosate after a lengthy review, which sparked a scientific storm.
. . . .
But that advice triggered a backlash, with 96 prominent experts, including almost the whole IARC team, taking the unusual step of calling for the Efsa decision to be disregarded.
Earlier this week, another 14 scientists signed a consensus statement in the Environmental Health journal, saying regulatory estimates of tolerable exposure levels for glyphosate were based on outdated science.
. . . .
The renewal calls for further studies on the endocrine disrupting potential of glyphosate to be completed before August.
However, environmentalists said the proposal flew in the face of a censure of the commission by the EU ombudsman, Emily O’Reilly, earlier this week for accepting proof of a pesticide’s safety after its use had already been authorised.
. . . .
EU national representatives will vote on whether to relicense glyphosate at a meeting in Brussels on 7 March.
Read full, original post: European commission plans to relicense controversial weedkiller